SPDR® S&P Biotech ETF
XBI
NYSE Arca
| Weiss Ratings | XBI - NYSE Arca | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Weak | |||
| Reward Grade | D+ | |||
| Risk Index | Weak | |||
| Risk Grade | D+ | |||
| Valuation | XBI - NYSE Arca | Click to Compare |
Click to Compare |
Click to Compare |
| Price | $75.93 | |||
| Company Info | XBI - NYSE Arca | Click to Compare |
Click to Compare |
Click to Compare |
| Provider | SPDR State Street Global Advisors | |||
| Manager/Tenure (Years) | Karl A. Schneider (10), Raymond Donofrio (8) | |||
| Website | http://https://www.spdrs.com | |||
| Phone Number | 617-786-3000 | |||
| Fund Information | XBI - NYSE Arca | Click to Compare |
Click to Compare |
Click to Compare |
| Fund Name | SPDR® S&P Biotech ETF | |||
| Category | Health | |||
| Sub-Category | Healthcare Sector Equity | |||
| Prospectus Objective | Specialty - Health | |||
| Inception Date | Jan 31, 2006 | |||
| Open/Closed To New Investors | Open | |||
| Minimum Initial Investment | -- | |||
| Minimum Subsequent Investment | -- | |||
| Front End Fee | -- | |||
| Back End Fee | -- | |||
| Dividends and Shares | XBI - NYSE Arca | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield | 0.17% | |||
| Dividend | XBI - NYSE Arca | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield (Forward) | 0.23% | |||
| Asset Allocation | XBI - NYSE Arca | Click to Compare |
Click to Compare |
Click to Compare |
| Cash | 0.09% | |||
| Stock | 99.91% | |||
| U.S. Stock | 97.18% | |||
| Non-U.S. Stock | 2.73% | |||
| Bond | 0.00% | |||
| U.S. Bond | 0.00% | |||
| Non-U.S. Bond | 0.00% | |||
| Preferred | 0.00% | |||
| Convertible | 0.00% | |||
| Other Net | 0.00% | |||
| Price History | XBI - NYSE Arca | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 6.17% | |||
| 30-Day Total Return | -11.75% | |||
| 60-Day Total Return | -16.85% | |||
| 90-Day Total Return | -13.64% | |||
| Year to Date Total Return | -15.67% | |||
| 1-Year Total Return | -8.73% | |||
| 2-Year Total Return | -6.35% | |||
| 3-Year Total Return | -8.88% | |||
| 5-Year Total Return | -16.66% | |||
| Price | XBI - NYSE Arca | Click to Compare |
Click to Compare |
Click to Compare |
| Closing Price | $75.93 | |||
| 1-Month Low Price | $69.80 | |||
| 1-Month High Price | $88.82 | |||
| 52-Week Low Price | $69.80 | |||
| 52-Week Low Price (Date) | Apr 08, 2025 | |||
| 52-Week High Price | $104.18 | |||
| 52-Week High Price (Date) | Nov 08, 2024 | |||
| NAV | XBI - NYSE Arca | Click to Compare |
Click to Compare |
Click to Compare |
| 1-Month Low NAV | $69.80 | |||
| 1-Month High NAV | $88.85 | |||
| 52-Week Low NAV | $69.80 | |||
| 52-Week Low NAV (Date) | Apr 08, 2025 | |||
| 52-Week High NAV | $104.11 | |||
| 52-Week High Price (Date) | Nov 08, 2024 | |||
| Beta / Standard Deviation | XBI - NYSE Arca | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 1.00 | |||
| Standard Deviation | 26.84 | |||
| Balance Sheet | XBI - NYSE Arca | Click to Compare |
Click to Compare |
Click to Compare |
| Total Assets | 5.12B | |||
| Operating Ratios | XBI - NYSE Arca | Click to Compare |
Click to Compare |
Click to Compare |
| Expense Ratio | 0.35% | |||
| Turnover Ratio | 90.00% | |||
| Performance | XBI - NYSE Arca | Click to Compare |
Click to Compare |
Click to Compare |
| Last Bull Market Total Return | 17.98% | |||
| Last Bear Market Total Return | -17.46% | |||